Yuandong Bio "Grom bromine ammonium injection" is about to be approved for the second time.

On October 14, Yuandong Bio3 generic drug Grombrom ammonium injection application entered the "in the approval" stage, is expected to be officially approved in the near future, becoming the second domestic pharmaceutical after Hengrui Pharmaceutical approved manufacturers.
Grome ammonium bromide injection is an anticholinel energy drug, mainly for pre-anesthesia and intraoperative drugs, used to fight muscle pine antagonists, such as Nismin drugs, such as intestinal peristaltic enhancement, increased secretions, bronchial spasms and slow heart rate and other toxic side effects.
the domestic preoperative use of anticholine drugs have atopyb, dong-dong-alkali and pyridoline hydrochloride, athosin as a clinical classic drug to date, clinical applications are widely used, but commonly used doses of atopine can be The heart rate is increased faster, and the inhibitory effect of east palladiumbase on the secretion of respiratory glands is slightly weaker than that of atopyin, and athosin, east palladiumortine and serotonin have been able to pass through the blood-brain barrier.
Compared with Athosin, ammonium Glon bromide inhibits salivary secretion for a strong and long-lasting effect, with low cardiovascular adverse reactions, and the drug lipid membrane has poor passability and is not easy to pass through the blood-brain barrier, thus affecting the central nervous system less.
bromide is an ideal alternative to ato.
ammonium bromide injection makes up for the shortage of existing clinical therapies and can better meet clinical needs.
global sales of approximately $180 million in 2017 (source: IQVIA database).
, the Glon bromine ammonium tablets of Dongting Pharmaceuticals and the Glon bromide injections of Hengrui Pharmaceuticals have been approved for market.
.